Tumors that were previously considered “IDH-mutant, secondary GBMs”, though histologically similar to primary GBMs, should be considered separate pathologies, as they are now defined as grade 4 astrocytomas [18]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).